The Coalition for a Prosperous America (CPA) today applauded a new bill by Rep. Jim Banks (R-IN-03) that would ban private pension plans from investing in the stocks and bonds of countries deemed adversarial by Washington. If passed, the Employee Retirement Income Security Act of 1974 (ERISA), a federal law that sets minimum standards for…
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
The House Financial Services Committee says American consumers are helped by a strong dollar, which lowers the price of imports to the tune of up to $45 billion per year in savings. In a $23 trillion economy, is an overvalued dollar really worth it?
China as a source for American imports is on the wane thanks to tariffs, other business risks. But strong dollar keeps imports booming.
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
Meet the Chinese companies banned by Commerce and the State Department, but still able to attract billions from Wall Street fund managers.
House Homeland Committee leadership say DoJ, FBI, and Homeland have all failed in stopping China espionage, IP theft.
At a recent House Ways & Means subcommittee hearing on trade, CEO Michael Stumo talks de minimis, and the inescapable realities of China’s forced labor.
Dan Kildee’s full floor speech in support of over-riding the President’s veto on House and Senate vote to end the White House solar emergency declaration started last June.
Times are changing. Where the GOP once stalwartly supported “free trade,” many Republicans are now openly questioning the effectiveness of U.S. trade policy. And in Congress, both Republicans and Democrats are looking to rewrite America’s problematic trading relationship with China. In particular, bipartisan consensus is emerging on the need to overhaul an obscure part of U.S. customs…
